The combined efforts of cell biologists, medicinal chemists and structural biologists will hopefully see some of those strategies come to fruition in the near future and provide tailor-made compounds for targeting SWI/SNF complexes in different types of cancer. The gene discussed is SMARCA1; the disease is cancer.